Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293313208> ?p ?o ?g. }
- W4293313208 endingPage "1457" @default.
- W4293313208 startingPage "1420" @default.
- W4293313208 abstract "Abstract: In the last decade, selective modulators of type-2 cannabinoid receptor (CB2) have become a major focus to target endocannabinoid signaling in humans. Indeed, heterogeneously expressed within our body, CB2 actively regulates several physio-pathological processes, thus representing a promising target for developing specific and safe therapeutic drugs. If CB2 modulation has been extensively studied since the very beginning for the treatment of pain and inflammation, the more recent involvement of this receptor in other pathological conditions has further strengthened the pursuit of novel CB2 agonists in the last five years. Against this background, here we discuss the most recent evidence of the protective effects of CB2 against pathological conditions, emphasizing central nervous system disorders, bone and synovial diseases, and cancer. We also summarize the most recent advances in the development of CB2 agonists, focusing on the correlation between different chemical classes and diverse therapeutic applications. Data mining includes a review of the CB2 ligands disclosed in patents also released in the last five years. Finally, we discuss how the recent elucidation of CB2 tertiary structure has provided new details for the rational design of novel and more selective CB2 agonists, thus supporting innovative strategies to develop effective therapeutics. Our overview of the current knowledge on CB2 agonists provides pivotal information on the structure and function of different classes of molecules and opens possible avenues for future research." @default.
- W4293313208 created "2022-08-27" @default.
- W4293313208 creator A5024737795 @default.
- W4293313208 creator A5029372344 @default.
- W4293313208 creator A5055677935 @default.
- W4293313208 creator A5074347557 @default.
- W4293313208 creator A5080436855 @default.
- W4293313208 creator A5084489352 @default.
- W4293313208 creator A5087671376 @default.
- W4293313208 date "2023-04-01" @default.
- W4293313208 modified "2023-10-08" @default.
- W4293313208 title "Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential" @default.
- W4293313208 cites W101798470 @default.
- W4293313208 cites W1434138403 @default.
- W4293313208 cites W1477485773 @default.
- W4293313208 cites W1503696655 @default.
- W4293313208 cites W1512507748 @default.
- W4293313208 cites W1530755879 @default.
- W4293313208 cites W1553123291 @default.
- W4293313208 cites W1596640114 @default.
- W4293313208 cites W1607901775 @default.
- W4293313208 cites W1685180105 @default.
- W4293313208 cites W1928757774 @default.
- W4293313208 cites W1928931031 @default.
- W4293313208 cites W1965546476 @default.
- W4293313208 cites W1969874679 @default.
- W4293313208 cites W1970255059 @default.
- W4293313208 cites W1971343912 @default.
- W4293313208 cites W1974642601 @default.
- W4293313208 cites W1981535223 @default.
- W4293313208 cites W1983701850 @default.
- W4293313208 cites W1984928289 @default.
- W4293313208 cites W1989437181 @default.
- W4293313208 cites W1990210398 @default.
- W4293313208 cites W1991311279 @default.
- W4293313208 cites W1991778481 @default.
- W4293313208 cites W1993039760 @default.
- W4293313208 cites W1993688922 @default.
- W4293313208 cites W1998165103 @default.
- W4293313208 cites W2001761766 @default.
- W4293313208 cites W2003338312 @default.
- W4293313208 cites W2005402932 @default.
- W4293313208 cites W2006320873 @default.
- W4293313208 cites W2006954988 @default.
- W4293313208 cites W2007143406 @default.
- W4293313208 cites W2009987061 @default.
- W4293313208 cites W2010079727 @default.
- W4293313208 cites W2011142394 @default.
- W4293313208 cites W2015943785 @default.
- W4293313208 cites W2017876495 @default.
- W4293313208 cites W2025562567 @default.
- W4293313208 cites W2027446984 @default.
- W4293313208 cites W2031163560 @default.
- W4293313208 cites W2031168104 @default.
- W4293313208 cites W2035401358 @default.
- W4293313208 cites W2037811574 @default.
- W4293313208 cites W2040032122 @default.
- W4293313208 cites W2041376729 @default.
- W4293313208 cites W2047373793 @default.
- W4293313208 cites W2047545003 @default.
- W4293313208 cites W2049413898 @default.
- W4293313208 cites W2054653962 @default.
- W4293313208 cites W2054961000 @default.
- W4293313208 cites W2056188558 @default.
- W4293313208 cites W2056772684 @default.
- W4293313208 cites W2057976080 @default.
- W4293313208 cites W2060414412 @default.
- W4293313208 cites W2062561340 @default.
- W4293313208 cites W2064209015 @default.
- W4293313208 cites W2065375414 @default.
- W4293313208 cites W2066681847 @default.
- W4293313208 cites W2066981032 @default.
- W4293313208 cites W2067181191 @default.
- W4293313208 cites W2070331662 @default.
- W4293313208 cites W2070535004 @default.
- W4293313208 cites W2071695275 @default.
- W4293313208 cites W2071991061 @default.
- W4293313208 cites W2074590245 @default.
- W4293313208 cites W2075894678 @default.
- W4293313208 cites W2081154988 @default.
- W4293313208 cites W2082237701 @default.
- W4293313208 cites W2084496548 @default.
- W4293313208 cites W2085052329 @default.
- W4293313208 cites W2091808474 @default.
- W4293313208 cites W2092760899 @default.
- W4293313208 cites W2093315658 @default.
- W4293313208 cites W2094296145 @default.
- W4293313208 cites W2102182608 @default.
- W4293313208 cites W2102377211 @default.
- W4293313208 cites W2103247095 @default.
- W4293313208 cites W2103617764 @default.
- W4293313208 cites W2111152176 @default.
- W4293313208 cites W2123587922 @default.
- W4293313208 cites W2123700490 @default.
- W4293313208 cites W2128022755 @default.
- W4293313208 cites W2130645298 @default.
- W4293313208 cites W2133551580 @default.
- W4293313208 cites W2138512826 @default.